Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCeramic Fuel Cells Regulatory News (CFU)

  • There is currently no data for CFU

Quarterly Cashflow Report

30 Jul 2014 09:26

RNS Number : 7136N
Ceramic Fuel Cells Limited
30 July 2014
 

30 July 2014

 

Cashflow Report for the June Quarter

 

Ceramic Fuel Cells Limited (AIM/ASX: CFU), today released its quarterly cashflow report for the June 2014 quarter.

Summary of the Quarter

· Sales volume - 71 units sold this quarter, 210 units sold in the twelve months ended 30 June 2014 (FY2013 - 147 units). This represents a 43% increase in unit sales over FY2013.

 

· Fundraising - successfully raised equity of £3.36M (A$6.11M) together with the entering into of an investor agreement for a minimum US$3.00M (A$3.20M or £1.76M) and up to US$8.50M (A$9.10M to £5.00M) over the twelve months to 28 February 2015. To 30 June, under the investor agreement, equity to the value of US$0.7M (A$0.74M, £0.41M) has been issued as well as US$0.25M (A$0.27M, £0.14M) of convertible notes.

 

· Cash for Ameland order received - 20 units for the Ameland order were despatched in May with the remaining 20 in June. All proceeds from the sale of these units were received by 30 June.

 

· Cash position at 30 June 2014 - A$5.31M (£2.92M).

 

· Announcement of major degradation improvements - on 30 June 2014 the Company announced that a substantial reduction (up to 70%) in stack degradation rates had been achieved following patented improvements to its BlueGEN product.

 

Operational Review

Overview

CFU makes small-scale generators that use proprietary fuel cell technology to convert natural gas into electricity and heat for homes and small commercial buildings. CFU has fully commercialised its technology into products, and in addition to selling these products to commercial customers in Europe, is focussing on developing a product that can undertake thermal cycling.

 

The Company has recently announced substantial reductions in degradation rates following the introduction of patented improvements to its BlueGEN product. Extensive in-house and in-field testing demonstrated reductions of up to 70% of the average degradation rate experienced in current customer BlueGEN products. These patented improvements, which significantly improve the efficiency of the product over the life of the stack, are presently being introduced into the supply chain and will then be incorporated into routine stack production. It is envisaged that these improvements will reduce the magnitude of the required future warranty provision per unit.

 

Market Developments and Sales

During the June quarter, 71 BlueGEN units were sold. Whilst this is a substantial improvement on the March quarter's 15 units, the Company has previously acknowledged that this level of sales will not sustain the business and is focusing its limited sales resources on large, project-based sales in both the UK and Europe. Development of these large-scale projects is progressing and the Board is confident that a number of these targeted projects will be converted into orders in the near future.

 

The Company sold 210 units for FY2014 which was a 43% increase on the previous year. The Company acknowledges that, whilst there is the basis to significantly increase sales volumes through project based schemes, there is also the opportunity to secure the business' future viability through actively pursuing strategic partnerships with a number of key distribution partners in Europe, Asia and North America.

In addition to distribution partners the Company has been approached to develop larger capacity units for certain markets. Such developments will require additional levels of resource and discussions are proceeding with a number of organisations to secure the appropriate financial support. These activities may lead to the Company becoming a multiple product business.

 

The Company remains in dialogue with Synergy International OÜ (SI), of Estonia, however until the situation is resolved no costs are being incurred in relation to potential SI sales.

 

A summary of the Company's sales performance by quarter since FY11 is as follows:

http://www.rns-pdf.londonstockexchange.com/rns/7136N_-2014-7-30.pdf

 

Monthly sales for the 12 months to 30 June 2014 were as follows:

http://www.rns-pdf.londonstockexchange.com/rns/7136N_-2014-7-30.pdf

 

Sales by geographical region for the 12 months to 30 June 2014 were as follows:

http://www.rns-pdf.londonstockexchange.com/rns/7136N_-2014-7-30.pdf

 

During the June quarter Ameland, in the Netherlands, purchased 40 units and 5 German installers purchased multiple units. The Company is pleased with the increase in sales via its installers given the reduction in its direct sales force in March. During the quarter Avilos took the first 2 units under their agreement with the Company.

 

Financial Review

June Quarter Cash Flows

Net operating cash outflow for the June quarter was A$2.95M (£1.62M). During the quarter, receipts from customers, including the receipt from Ameland, amounted to A$2.00M (£1.10M) and operating expense cash outflow was A$5.10M (£2.80M). The quarter's net operating cash outflow compares to the March quarter's net operating cash outflow of A$8.06M (£4.43M), the December 2013 quarter's outflow of A$1.22M (£0.67M) and the September 2013 quarter's outflow of A$6.03M (£3.30M). The December 2013 quarter's net operating cash outflow was materially reduced by the receipt of a tax refund of A$4.02M (£2.21M) for research and development expenditure for FY2013, hence the operating cash outflow before the tax receipt was A$5.24M (£2.88M). It is anticipated that a research and development tax refund will be received for FY2014 in the last quarter of CY2014.

 

During March 2014 the Company undertook a review of its operations which led to a restructure in all countries in which it operates. This has led to a reduction in its work force and a lowering of its operational and production costs. The benefits of this restructure began to be realised during the June quarter as demonstrated by the reduced cash outflow for the quarter with further savings to be realised over the coming months.

 

The Board continues its strategic review of the Company's financial and operational needs along with its pursuit of joint venture possibilities with partners who are willing to pay for the Company's technology or can add significant synergies to the Company's operations.

 

Net investing cash flow for the quarter was an outflow of A$0.012M (£0.007M). The outflow was for the acquisition of plant and equipment.

 

Net financing cash flow for the quarter was an inflow of A$6.09M (£3.35M). Of the amount, A$6.11M (£3.36M) was received from the equity placement approved by shareholders at the EGM on 28 April. The balance of the proceeds from the issue of shares was received under the investor agreement announced in March. The capital raise expenses disclosed in the Appendix 4C cover the majority of the equity placement and investor agreement expenses, with further cash outflows for these in the coming quarters.

 

Cash on hand at 31 March 2014 was A$2.29M (£1.26M).

 

Cash on hand at 30 June 2014 was A$5.31M (£2.92M).

 

 

 

For more information please contact:

 

 

Ceramic Fuel Cells Limited

 

 

 

 

 

 

Clifford Ashby (CFO)

 

Bob Kennett (CEO)

 

 

Tel.

Email

Tel.

Email

 

 

: +61 (0) 3 9554 2300

: investor@cfcl.com.au

: +44 776 4200661

: investor@cfcl.com.au

 

Arden Partners Plc (AIM Nomad)

Steve Douglas Tel. : +44 (0) 12 1423 8900

 

 

 

 

 

 

About Ceramic Fuel Cells Limited:

 

Ceramic Fuel Cells is a world leader in developing fuel cell technology to generate highly efficient and low-emission electricity from widely available natural gas. Ceramic Fuel Cells has sold its BlueGEN gas-to-electricity generator to major utilities and other foundation customers in Germany, the United Kingdom, Switzerland, The Netherlands, Italy, Japan, Australia, and the USA. Ceramic Fuel Cells is now focusing on markets in Germany, the United Kingdom and Benelux.

The company is listed on the London Stock Exchange AIM market and the Australian Securities Exchange (code CFU).

www.cfcl.com.au

www.bluegen.info

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSDESASFLSEEW
Date   Source Headline
3rd Mar 20158:54 amRNSResignation of Nominated Advisor
2nd Mar 20157:30 amRNSSuspension - Ceramic Fuel Cells Limited
2nd Mar 20157:00 amRNSAppointment of Voluntary Administrators
24th Feb 20157:00 amRNSListed options exercised
24th Feb 20157:00 amRNSTermination of Bergen Agreement
11th Feb 20157:00 amRNSTechnology Update
5th Feb 20157:19 amRNSConversion of Loan Notes
3rd Feb 20157:00 amRNSAdmission of Shares
29th Jan 20157:00 amRNSConversion of Loan Notes
29th Jan 20157:00 amRNSQuarterly Cashflow Report
21st Jan 20157:00 amRNSConversion of Loan Notes
20th Jan 20157:00 amRNSTechnology Update
14th Jan 20157:00 amRNSAdmission of Shares
9th Jan 20157:00 amRNSConversion of Loan Notes
8th Jan 20157:00 amRNSChanges to Germany's Incentives for microCHPs
6th Jan 20157:00 amRNSCPs for iPower BlueGEN programme completed
24th Dec 20147:00 amRNSConversion of Loan Notes
17th Dec 20147:00 amRNSIssue of Shares and Options to Staff
15th Dec 20147:00 amRNSAdmission of shares on exercise of options
26th Nov 20147:00 amRNSIssue of Shares and Grant of Options
24th Nov 20147:00 amRNSResults of Pro Rata Renounceable Rights Issue
21st Nov 20141:39 pmRNSAdmission of Shares
20th Nov 20149:14 amRNSResults of Annual General Meeting
20th Nov 20147:00 amRNSCFCL AGM Chairman's Address to Shareholders
17th Nov 20147:00 amRNSFirst fully funded BlueGEN programme with iPower
7th Nov 20147:00 amRNSFurther extension to closing date for Rights Issue
31st Oct 20147:00 amRNSTax Refund Received
29th Oct 20147:00 amRNSQuarterly Cashflow Report
24th Oct 20147:00 amRNSExtension to Rights Issue Closing Date
21st Oct 20147:00 amRNSConfirmation of Dispatch of AGM
17th Oct 20149:00 amRNSAdmission of Shares
8th Oct 20147:00 amRNSDespatch of Prospectus and Associated Documents
3rd Oct 20147:00 amRNSLetter to Qualifying Shareholders
3rd Oct 20147:00 amRNSLetter to Optionholders
3rd Oct 20147:00 amRNSLetter to Non-Qualifying Shareholders
29th Sep 20147:00 amRNSRights Issue Prospectus
26th Sep 20147:00 amRNSAnnual Report
12th Sep 20147:00 amRNSOperations Update
10th Sep 20147:00 amRNSAdmission of Shares
19th Aug 20147:00 amRNSPreliminary Final Report
1st Aug 20147:00 amRNSChanges to the Board
30th Jul 20149:26 amRNSQuarterly Cashflow Report
30th Jul 20147:00 amRNSAIM Admission
30th Jun 20147:00 amRNSTechnology Update
27th Jun 20147:00 amRNSAdmission of Shares
24th Jun 201411:48 amRNSHolding(s) in Company
11th Jun 201410:41 amRNSAdmission of Shares
16th May 20148:54 amRNSHolding(s) in Company
30th Apr 20147:01 amRNSQuarterly Cashflow Report
28th Apr 201410:20 amRNSExtraordinary General Meeting Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.